Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Carrasco Valiente

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Archivos Espanoles De Urologia|February 22, 2017
[Epidemiology of urinary lithiasis in Spain: New scenarios.]Julia Carrasco Valiente, Enrique Gómez Gómez, María José Requena Tapia
Archivos Espanoles De Urologia|April 11, 2018
[Oligometastatic prostate cancer. concept and implications.]Julia Carrasco Valiente, Jesús Manuel Ruiz García, María José Requena Tapia
Archivos Espanoles De Urologia|March 25, 2022
Serum biomarkers for diagnosis and characterization of prostate cancerEnrique Gómez Gómez, Ignacio Puche Sanz, J Valero Rosa, et al.
Urology|February 9, 2010
Hand metastasis from renal carcinomaFrancisco J Anglada-Curado, Jesús De Haro-Padilla, Julia Carrasco-Valiente, et al.
Urology|October 28, 2017
New Approach to Guide Target Prostate Biopsy: Technique and Initial ExperienceEnrique Gómez Gómez, José Valero Rosa, Julia Carrasco Valiente, et al.
Medicina Clinica|May 10, 2016
[Prevalence of urolithiasis in the 40 to 65 year old Spanish population: The PreLiRenE study]María Raquel Arias Vega, Luis Angel Pérula de Torres, Julia Carrasco Valiente, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?Enrique Gomez-Gomez, Sara Moreno Sorribas, Jose Valero-Rosa, et al.
Medicina Clinica|May 22, 2017
Comorbidity and socio-demographic factors associated with renal lithiasis in persons aged 40 to 65: A cross-sectional studyRaquel Arias Vega, Luis Angel Pérula de Torres, Celia Jiménez García, et al.
Korean Journal of Radiology|December 8, 2020
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active SurveillanceJoseba Salguero, Enrique Gómez-Gómez, José Valero-Rosa, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Archivos Espanoles De Urologia|February 22, 2017
[Epidemiology of urinary lithiasis in Spain: New scenarios.]Julia Carrasco Valiente, Enrique Gómez Gómez, María José Requena Tapia
Archivos Espanoles De Urologia|April 11, 2018
[Oligometastatic prostate cancer. concept and implications.]Julia Carrasco Valiente, Jesús Manuel Ruiz García, María José Requena Tapia
Archivos Espanoles De Urologia|March 25, 2022
Serum biomarkers for diagnosis and characterization of prostate cancerEnrique Gómez Gómez, Ignacio Puche Sanz, J Valero Rosa, et al.
Urology|February 9, 2010
Hand metastasis from renal carcinomaFrancisco J Anglada-Curado, Jesús De Haro-Padilla, Julia Carrasco-Valiente, et al.
Urology|October 28, 2017
New Approach to Guide Target Prostate Biopsy: Technique and Initial ExperienceEnrique Gómez Gómez, José Valero Rosa, Julia Carrasco Valiente, et al.
Medicina Clinica|May 10, 2016
[Prevalence of urolithiasis in the 40 to 65 year old Spanish population: The PreLiRenE study]María Raquel Arias Vega, Luis Angel Pérula de Torres, Julia Carrasco Valiente, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2019
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancerAna Blanca, Alvaro Sanchez-Gonzalez, Maria J Requena, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?Enrique Gomez-Gomez, Sara Moreno Sorribas, Jose Valero-Rosa, et al.
Medicina Clinica|May 22, 2017
Comorbidity and socio-demographic factors associated with renal lithiasis in persons aged 40 to 65: A cross-sectional studyRaquel Arias Vega, Luis Angel Pérula de Torres, Celia Jiménez García, et al.
Korean Journal of Radiology|December 8, 2020
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active SurveillanceJoseba Salguero, Enrique Gómez-Gómez, José Valero-Rosa, et al.
Pageof 3